This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MINUTO, F. Articles by GIORDANO, G. Search for Related Content PubMed PubMed Citation Articles by MINUTO, F. Articles by GIORDANO, G.

Immunoreactive Insulin-Like Growth Factor I (IGF-I) and IGF-I-Binding Protein Content in Human Thyroid Tissue^*

Cattedre di Fisiopatologia Endocrina (F.M.) e di Endocrinologia (A.B., P.D.M., G.C., G.G.), ISMI, and Istituto di Clinica Chirurgica R (G.C.T.), University of Genova Genova, Italy

Address requests for reprints to: Francesco Minuto, Cattedra di Fisiopatologia Endocrina, ISMI, Viale Benedetto XV 6, I-16132 Genova, Italy.

We measured immunoreactive insulin-like growth factor I (IGF-I) in extracts of normal and nodular thyroid tissue obtained at surgery from patients with nontoxic goiter. The nodular tissues contained a higher concentration [mean, 279.0 ± 69.7 (±SE) mU/g] than paired normal tissues (115.5 ± 17.9 mU/g; P = 0.024; n = 12); a difference was evident in all but one patient. Sephadex G-50 gel filtration of tissue extracts revealed two immunoreactive peaks, the first in the void volume of the column, and the second in the elution volume of authentic IGF-I. The first peak was identified as IGF-I-binding protein by sodium dodecyl sulfate-polyacrylamide gel electrophoresis after cross-linking with iodinated IGF-I. Isolated thyroid cell membranes contained high affinity IGF-I-binding sites of similar affinity and numbers in both normal and nodular thyroid tissue. The IGF-I content of six thyroid cancer extracts was higher than that of normal thyroid tissue, but the IGF-I content of thyroid tissue from six patients with Graves’ disease and five patients with Hashimoto’s thyroiditis was similar to that in normal thyroid tissue.

These data suggest that the stimulatory effect of TSH on thyroid cell proliferation could be mediated through IGF-I action and suggest that an increase in IGF-I production could sustain the goitrogenic process.

^* This work was supported by CNR Research Grants 87.01359.44 (under the special project Oncology) and 87.01562.04 and a Ministero della Pubblica Istruzione research grant.

Received July 7, 1988.

This article has been cited by other articles:

				H. Volzke, N. Friedrich, S. Schipf, R. Haring, J. Ludemann, M. Nauck, M. Dorr, G. Brabant, and H. Wallaschofski Association between Serum Insulin-Like Growth Factor-I Levels and Thyroid Disorders in a Population-Based Study J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4039 - 4045. [Abstract] [Full Text] [PDF]

				A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF]

				H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth Endocr. Rev., June 1, 2000; 21(3): 215 - 244. [Abstract] [Full Text]